Skip to main content
Vifor Pharma AG logo

Vifor Pharma AG — Investor Relations & Filings

Ticker · VIFN ISIN · CH0364749348 LEI · 529900KO6CN2D9OE1F19 SW Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CH Switzerland
Listing SW VIFN

About Vifor Pharma AG

https://www.viforpharma.com/

Vifor Pharma AG, now operating as CSL Vifor, is a global pharmaceutical company that develops, manufactures, and markets products for severe and chronic diseases. It is a global leader in therapies for iron deficiency and iron deficiency anemia, with applications in heart failure, kidney disease, gastroenterology, and women's health. The company also has a strong and growing presence in nephrology, aiming to address the full spectrum of kidney disease through its joint company with Fresenius Medical Care Renal Pharma. Vifor Pharma's business model includes strategic global partnering, in-licensing, and the development of innovative therapies to address significant unmet medical needs.

Recent filings

No filings indexed yet

We are still gathering filings for Vifor Pharma AG. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.